Moore's Compounding Pharmacy

Form 483 issued January 13, 2017 · Corpus Christi, Texas

Inspection
Jan 4 – Jan 13, 2017
Observations
1
Pages
1
FEI number
3011759873

In short: On January 13, 2017, FDA issued a Form 483 with 1 observation to Moore's Compounding Pharmacy in Corpus Christi, Texas (FEI 3011759873) after an inspection that ran Jan 4 – Jan 13, 2017. The investigator was Patty P. Kaewussdangkul. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent objectionable microorganisms in drug products not required to be…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Moore's Compounding Pharmacy?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Moore's Compounding Pharmacy?

Patty P. Kaewussdangkul is named on this Form 483, for the inspection of Jan 4 – Jan 13, 2017. Each investigator has a profile showing what they cite most.

When was Moore's Compounding Pharmacy inspected by FDA?

The inspection ran Jan 4 – Jan 13, 2017, and the Form 483 is dated January 13, 2017.

How do I get the full Form 483 for Moore's Compounding Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free